跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Vildaxil - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Vildaxil
Approved
STANDARD
Vildaxil
Globela Pharma Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d08e70b06ff4630e
Company
Globela Pharma Private Limited
Type
Standard
Approval Details
Approval Id
d08e70b06ff4630e
Drug Approval Philippines Name
Vildaxil
Product Name
Vildaxil
Registration Number
DRP-12199
Brand Name
Vildaxil
Generic Name
Vildagliptin
Dosage Form
Tablet
Dosage Strength
50 mg
Manufacturer
Globela Pharma Private Limited
Importer
AMB HK Enterprises, Inc.
Distributor
AMB HK Enterprises, Inc.
Issuance Date
29 June 2022
Expiry Date
29 June 2027
Pharmacologic Category
Blood Glucose Lowering Drug [Dipeptidyl Peptidase 4 (DPP-4) Inhibitor]
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d08e70b06ff4630e
Type
Standard
Back to Philippines FDA Approvals